
Aspen Neuroscience, Inc. (ASPE)
Last updated: 2026-11-03 13:30:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
Aspen Neuroscience, Inc. (ASPE) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $13.13, with a market capitalization of $432.98M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $11.60 to $14.90. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$432.98M | |
$12.75 | |
$14.90 | |
$11.60 | |
$13.04 | |
90.00 | |
959.65K | |
-- | |
$14.90 | |
$11.60 | |
-- | |
-- |
Aspen Neuroscience, Inc. (ASPE) Pre-Market Stock Price
Aspen Neuroscience, Inc. (ASPE) is trading at $13.13 in pre-market trading as of 2026-11-03 13:25:00, up 0.71% ($0.09) from the previous close of $13.04
Pre-market trading shows how investors are pricing ASPE before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Aspen Neuroscience, Inc. (ASPE) 7-Day Stock Price Change
Over the past seven days, Aspen Neuroscience, Inc. (ASPE) moved from $14.89 to $13.13, representing a decline of 11.80% ($1.76).
The stock traded between $11.60 and $14.90 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 959.65 thousand shares, -- versus the previous seven-day period, indicating -- trading activity.
ASPE 52-Week Price Position
Position in Range: 46.5%
ASPE is currently trading at $13.13, placing it 46.5% of the way from its 52-week low of $11.60 to its 52-week high of $14.90. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Aspen Neuroscience, Inc. (ASPE)?
Aspen Neuroscience Inc is a clinical-stage, regenerative medicine biotechnology company focused on developing autologous induced-pluripotent stem cell (iPSC)-derived therapies to initially address neurodegenerative diseases with high unmet medical need. The company's flagship program, sasineprocel, is an investigational autologous iPSC-based therapy for Parkinson's disease designed to replace a patient's lost dopamine neurons with dopaminergic neuron precursor cells.
Aspen Neuroscience, Inc. Information
| Exchange | NASDAQ |
| Company Website |
How to Buy Aspen Neuroscience, Inc. (ASPE) Stock on MEXC
Eligible investors can buy real shares of Aspen Neuroscience, Inc. (ASPE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Aspen Neuroscience, Inc. (ASPE) stock price today?
2.Is ASPE stock going up or down today?
3.What is ASPE pre-market price?
4.What is ASPE after-hours price?
5.Is ASPE stock trading now?
6.Where does ASPE sit relative to its 52-week high and low?
7.What sector is Aspen Neuroscience, Inc. in?
8.What is Aspen Neuroscience, Inc.'s market capitalization and where is it listed?
9.How is ASPE valued in terms of P/E ratio and EPS?
10.Does Aspen Neuroscience, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
ASPE Stock Calculator
Estimate the value between ASPE shares and USD.
ASPE Shares to USD
1.00 ASPE shares = 13.133 USD
Calculations are estimates based on the latest available price and are for reference only.


